Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-negative bacteria cell membrane is a structural component of Gram-negative bacteria, consisting of a complex cell envelope with an outer membrane, a thin peptidoglycan layer, and an inner (cytoplasmic) membrane. The outer membrane contains lipopolysaccharides (LPS), which act as potent endotoxins and are critical for immune system interactions and virulence[1][4][5]. The cell membrane structure is a barrier to many antibiotics, detergents, and dyes, contributing to Gram-negative bacteria’s notable antibiotic resistance[2][4]. This envelope plays crucial roles in protecting the bacteria from environmental threats, facilitating nutrient transport (via porins and transporters), and anchoring factors involved in adhesion and virulence[1][4][5]. Note: The membrane itself is not a direct drug target but is essential in mediating drug interaction, resistance, and virulence factors. The term "Aerobic Gram-negative bacteria cell membrane" is not a canonical therapeutic target but rather a general structural feature of a broad class of bacteria. Individual membrane proteins (e.g., efflux pumps, porins, LPS) within this membrane are considered drug targets, but the collective membrane is not typically classified as a single target[4][5].
Inhibition of cell wall synthesis (by β-lactams targeting penicillin-binding proteins) Disruption of membrane integrity (by polymyxins)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-negative bacteria cell membrane.